Evidence map›Paper›PMID 35163859›Full record

ArticleMolecules (Basel, Switzerland)2022

Effects of rAmb a 1-Loaded PLGA-PEG Nanoparticles in a Murine Model of Allergic Conjunctivitis.

Hui Cao, Ling Liu, Junyi Wang, Miao Gong, Ruyi Yuan, Jiahua Lu, Xiaojun Xiao, Xiaoyu Liu

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Molecules (Basel, Switzerland), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
3.0field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 16 citations in OpenAlex.

  1. Article
  2. Nanotechnology-Based Treatment for Ophthalmic Diseases.International journal of nanomedicine · 2026
    Review
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Review
  10. Review
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Hui CaoState Key Laboratory of Respiratory Disease for Allergy at Shenzhen University, Shenzhen Key Laboratory of Allergy & Immunology, Shenzhen University School of Medicine, Shenzhen 518061, China.
Ling LiuState Key Laboratory of Respiratory Disease for Allergy at Shenzhen University, Shenzhen Key Laboratory of Allergy & Immunology, Shenzhen University School of Medicine, Shenzhen 518061, China.
Junyi WangState Key Laboratory of Respiratory Disease for Allergy at Shenzhen University, Shenzhen Key Laboratory of Allergy & Immunology, Shenzhen University School of Medicine, Shenzhen 518061, China.
Miao GongDepartment of Respirology & Allergy, Third Affiliated Hospital of Shenzhen University, Shenzhen 518020, China.
Ruyi YuanState Key Laboratory of Respiratory Disease for Allergy at Shenzhen University, Shenzhen Key Laboratory of Allergy & Immunology, Shenzhen University School of Medicine, Shenzhen 518061, China.
Jiahua LuState Key Laboratory of Respiratory Disease for Allergy at Shenzhen University, Shenzhen Key Laboratory of Allergy & Immunology, Shenzhen University School of Medicine, Shenzhen 518061, China.
Xiaojun XiaoState Key Laboratory of Respiratory Disease for Allergy at Shenzhen University, Shenzhen Key Laboratory of Allergy & Immunology, Shenzhen University School of Medicine, Shenzhen 518061, China.
Xiaoyu LiuState Key Laboratory of Respiratory Disease for Allergy at Shenzhen University, Shenzhen Key Laboratory of Allergy & Immunology, Shenzhen University School of Medicine, Shenzhen 518061, China.
Shenzhen University · CNSecond Affiliated Hospital of Chengdu University of Traditional Chinese · CN

Funding

Key Science and Technology Plan Project of Zigong City 2019YYJC26Science and Technology Planning Project of Guangdong Province 2020A1515010029Science and Technology Program of Nanshan LHTD20180007Science and Technology Program of Shenzhen KQTD20170331145453160, JCYJ20180306171550045, GJHZ20190822095605512State Key Laboratory of Respiratory Disease SKLRD-Z-202111, SKLRD-OP-201910, SKLRD-Z-202216The National Natural Science Foundation No.81971514, 81803202
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

AllergensAmbrosiaAnimalsAntigens, PlantConjunctivitis, AllergicCytokinesGene Expression RegulationImmunoglobulin EMaleMiceMice, Inbred BALB CNanoparticlesPlant ProteinsPolyestersPolyethylene GlycolsRecombinant ProteinsAllergensAmb a I protein, Ambrosia artemisiifoliaAntigens, PlantCytokinesImmunoglobulin EPlant ProteinsPolyesterspolyethylene glycol-poly(lactide-co-glycolide)Polyethylene GlycolsRecombinant Proteinsallergenallergen-specific immunotherapyallergic conjunctivitisAmb a 1poly(DL-lactide-co-glycolide)-polyethylene glycol (PLGA-PEG)

Identifiers

PMID35163859
PMCPMC8837990
OpenAlexW4206067220

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.